ナジフロキサシン(124858-35-1)

ChemicalBook Optimization Suppliers
名前: Beijing Mediking Biopharm Co., Ltd  Gold
電話番号: 010-81769521,89753524,81760121 15901403431
電子メール: sales01@mediking.cn
名前: Tenghua Tech  Gold
電話番号: 13212769786
電子メール: 2024685872@qq.com
名前: Zibo ChemYuan Pharmaceutical Co., Ltd.  Gold
電話番号: 0533-2766162 13011630869
電子メール: zbchemyuan@163.com
名前: CHENGHUI PHARMACEUTICAL GROUP LTD  Gold
電話番号: 0531-58897070 15254140813
電子メール: market@jnchsd.com
名前: J & K SCIENTIFIC LTD.  
電話番号: 010-82848833 400-666-7788
電子メール: jkinfo@jkchemical.com
ナジフロキサシン 製品概要
化学名:ナジフロキサシン
英語化学名:Nadifloxacin
别名:NDFX;Nadifiloxacin;NadifloxacinAPI;7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-Methyl-4-oxo-1-azatricyclo[7.3.1.0^{5,13}]trideca-2,5(13),6,8-tetraene-3-carboxylic acid;9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid;NADIFLOXACIN;9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic Acid;Acuati
CAS番号:124858-35-1
分子式:C19H21FN2O4
分子量:360.38
EINECS:638-863-6
カテゴリ情報:ACUATIM;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:124858-35-1.mol
ナジフロキサシン
ナジフロキサシン 物理性質
融点 245-2470C (dec)
沸点 624.9±55.0 °C(Predicted)
比重(密度) 1.46±0.1 g/cm3(Predicted)
貯蔵温度 Sealed in dry,Store in freezer, under -20°C
溶解性DMSO (Slightly), Methanol (Sparingly, Heated)
外見 White to yellow crystalline solid.
酸解離定数(Pka)5.55±0.40(Predicted)
White to Off-White
Merck 14,6345
InChIInChI=1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26)
InChIKeyJYJTVFIEFKZWCJ-UHFFFAOYSA-N
SMILESC12=CC(F)=C(N3CCC(O)CC3)C3=C1N(C(C)CC3)C=C(C(O)=O)C2=O
CAS データベース124858-35-1(CAS DataBase Reference)
安全性情報
HSコード 2933.99.7500
毒性LD50 male, female mice and rats (mg/kg): 376.5, 420.6, 225.7, 240.5 i.v. (Hashimoto)
ナジフロキサシン Usage And Synthesis
外観白色~黄色、結晶~粉末
溶解性水酸化ナトリウム溶液に溶ける。
用途ニューキノロン系抗菌剤です。 DNA ジャイレースを阻害します。抗菌スペ クトルは非常に広く、アクネ菌及び表皮ブド ウ菌球菌を含むグラム陽性菌、グラム陰性菌 に対して、強い抗菌作用を示します。MRSA、 キノロン耐性 MRSA に対しても抗菌作用を示 します。
効能抗菌薬, 核酸合成阻害薬
商品名アクアチム (大塚製薬); アクアチム (大塚製薬); アクアチム (大塚製薬)
説明Nadifloxacin, one of the three new fluoroquinolone antibiotics launched in 1993 is indicated for topical treatment of acne vulgaris and other skin infections. Nadifloxacin has a potent and broad spectrum of activity against aerobic Gram-positive and -negative bacteria and against anaerobic bacteria. It produces significant improvement in patients with Propionibacterium acnes infection and does not appear to cause cross-resistance to other antibiotic agents. Its potent antimicrobial activity has also been demonstrated in the Pseudomonas aeruginosa burn wound infection model in mice. Nadifloxacin exerts its antibiotic activity by inhibiting the formation of supercoiled DNA by DNA gyrase.
化学的特性Off-White Crystalline Solid
OriginatorOtsuka (Japan)
使用Nadifloxacin is a topical fluorinated quinolone antibacterial used to treat skin conditions such as acne and other dermal infections caused by bacteria. This drug belongs to a class of calcium salt of polyacrylic acid crosslinked with divinyl glycol with minimal AEs.
定義ChEBI: Nadifloxacin is a pyridoquinoline, a hydroxypiperidine, a heteroarylpiperidine and a quinolone antibiotic. It has a role as an antibacterial drug. It is effective against the Gram-positive bacteria S. aureus and P. acnes, as well as Gram-negative bacteria.
brand nameAcuatim
応用例(製薬)A lipophilic tricyclic fluorobenzoquinoline with a 4- hydroxylpiperinyl moiety at the C-8 position, formulated as a cream for topical use. It is active against many Grampositive bacteria involved in skin infections, including Propionibacterium acnes (MIC 0.25–2.0 mg/L), and Staph. aureus (MIC 0.015–2 mg/L). It appears to inhibit the generation of reactive oxygen species by neutrophils. The sodium salt is used as a 1% cream for use in acne vulgaris and cutaneous staphylococcal infections.
Tags:124858-35-1